RT Journal Article
SR Electronic
T1 UK Defence Medical Services Guidance for the Use of Recombinant Factor VIIA (RFVIIA) in the Deployed Military Setting
JF Journal of the Royal Army Medical Corps
JO J R Army Med Corps
FD British Medical Journal Publishing Group
SP 307
OP 309
DO 10.1136/jramc-153-04-18
VO 153
IS 4
A1 TJ Hodgetts
A1 E Kirkman
A1 PF Mahoney
A1 R Russell
A1 R Thomas
A1 M Midwinter
YR 2007
UL http://militaryhealth.bmj.com/content/153/4/307.abstract
AB Use of recombinant Factor VIIa (rFVIIa) for trauma is currently an ‘off label’ use. There are reports of rFVIIa contributing to the successful outcome of military trauma patients. This paper sets out the current position of the UK Defence Medical Services with regard to using rFVIIa in military trauma.